HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Redken seeking Facebook blondes

This article was originally published in The Rose Sheet

Executive Summary

L'Oreal salon brand invites fair-haired women to upload their photo to its 10,000 Blondes application on social networking site Facebook.com; participants can learn about Redken products formulated specially for blond hair - which tends to be drier and more fragile and "can look duller as shine is less reflective," the company says - and enter to win a free sample from brand's Blonde Glam hair-care collection. "We know that our consumers love to use social media as a tool for beauty inspiration or to share their latest looks," says Rachel Weiss, Redken's senior director of interactive. "Photos are also a huge part of social activities on Facebook and we want Redken to be a part of this social media rise ... and this launch was the perfect opportunity to leverage this trend." Newest additions to Blonde Glam line are Perfect Platinum and Rich Vanilla color enhancers fortified with Redken's Interbond Conditioning System and Crystal Shine Complex, which deliver mica, grapefruit extract and grape seed oil, among other actives, to nourish and protect hair and maintain salon effects

You may also be interested in...

Impella Safety Update: Data Supports Pump For Qualified Patients

Updated data from a postmarket study of Abiomed’s Impella RP right-heart pump further supports the device’s safety for a specific patient population.

Quality, Safety, MDSAP A Focus For Medtech In New USMCA Trade Agreement

The new US-Mexico-Canada (USMCA) trade agreement includes language on enhancing regulatory compatibility between the three countries by recognizing quality systems audits performed under the Medical Device Single Audit Program (MDSAP). It also stipulates that each trading partner “consider its resources and technical capacity” in ensuring the safety, effectiveness and quality of devices – and more. Medtech industry advocacy group AdvaMed is praising the deal, reached by the three countries on 10 December.

Novo Nordisk Targets Smart Insulin, Stem Cell-Therapies

Novo Nordisk’s CEO talks to Scrip about the promise of glucose-responsive insulin, stem cell therapy, and a diabetes landscape without Sanofi.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts